Home » Newsletters » BioWorld Science

BioWorld Science

July 27, 1999

View Archived Issues

Abbott makes major strides in R&D during Q2

Competitive Technologies' ribozymes offer promise in gene therapy approaches

Cerus initiates phase III U.S. trial of platelet pathogen inactivation system

Alza expands promotion of Ditropan XL for overactive bladder

Idec Pharmaceuticals development highlights during second quarter

AHP's pneumococcal conjugate vaccine receives priority review status

Clinical program initiated for CEP-1347 in neurodegenerative disease therapy

Fujisawa initiates enrollment in phase III RA trial of Prograf

Phase I trial results reported for MSI pulmonary delivery of morphine

Patient enrollment completed in Anogesic phase III trial

Progenics awarded two grants from NIH for HIV programs

Novel class of acetylcholine receptor ligands discovered by Sibia researchers

Cytokine production inhibitors from SB particularly useful for inflammation, osteoporosis

Chroman-based beta3-adrenoceptor agonists in development at Bayer

Novel BZ-site GABA-A receptor ligands disclosed by Sanofi-Synthelabo

New agents for glaucoma disclosed by Alcon in recent patent literature

Bayer presents new anticancer compounds that inhibit Raf kinase

Antiobesity compounds in the Novartis pipeline

Gacyclidine displays therapeutic window of up to one hour in rat model of focal cerebral ischemia

Dual antioxidant/nNOS inhibitor effective in animal models of cerebral ischemia and brain injury

Nitrosylated alpha-adrenoceptor antagonists as potential agents for impotence

FDA requests additional data to support n-docosanol NDA

BM-113: pharmacokinetics and metabolism in rats following oral and intravenous dosing

Magainin's Locilex cream not approvable says FDA

Elan to develop Antegren for chronic treatment of MS

Continuous infusion of toborinone preferable in heart failure developing after cardiac surgery

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
UK Biobank delivers largest metabolomics dataset of 500K profiles
BioWorld Science
It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of 249 metabolites in the blood of its...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...